PaxMedica, Inc. (PXMD) has released an update to notify the public and investors about its officers.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
PaxMedica, Inc.’s Board approved the acceleration of vesting for certain restricted stock units (RSUs) to lessen administrative burdens. Key executives, including President and CEO Howard Weisman, CFO and COO Stephen Sheldon, and Chief Medical Officer Dr. David Hough, will benefit from this acceleration. The accelerated RSUs, whose values are based on the company’s closing stock price, will fully vest the day after the annual report is filed, contingent upon continued employment.
For further insights into PXMD corporate activity, check out TipRanks’ Insiders Trading Activity page.
